Model development for the prediction of toxicity and prognosis in Korean elderly cancer patients receiving chemotherapy: a multicenter prospective study
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0001071
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
? Age: 70 years or more
? Ineligibility for local therapy (surgery or radiotherapy): including inoperable patients due to their medical condition
? Histologically confirmed solid tumor
? Signed in written inforemd consent form
Exclusion Criteria
? Not a candidate for 1st line systemic chemotherapy
? Monotherapy with biologic agent/targeted agent, combination therapy with investigational agent, monotherapy with oral agent
? Hematologic malignancies (lymphoma, leukemia, multiple myeloma etc)
? Recurrent disease within 6 months from last day of adjuvant chemotherapy
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grade 3-5 toxicity by NCI-CTC AE version 4.0
- Secondary Outcome Measures
Name Time Method survival;drug compliance and frequency of dose modification;bone density and fracture rate